it is only a guess, Pierre, but i think that the lack of recent news is because of the Board's strong desire to integrate an announcement about the need of more exploration expenditure with an announcement about raising the necessary capital to do that.
Imo, Steam Engine should be the force behind the getting in of $$$$$.
That would mean, if I am on the right track of course, that the Bottletree assays are of little relevance, at present anyway. They will be of relevance of course once the money situation is assured, but in the meantime, the releasing of the results from those 3 drilled holes won't add anything of real substance.
I would be surprised to be told that the assays have not been done and assessed by HQ. Also, I would not be surprised to learn that they are not price-sensitive ('material' etc), meaning that they would not be required by law to be released via the ASX pronto.
I make this post purely to express my thoughts as to why the ASX has been not told of the assays for Bottletree, nor the Steam Engine 'options report', nor the direction the Board is taking on exploration. I could be quite wrong, but I cannot think of any other valid reason for the lack of news, the lack of news on anything.
- Forums
- ASX - By Stock
- SPQ
- Ann: Phase 2 Drilling Program commences at Bottletree
Ann: Phase 2 Drilling Program commences at Bottletree, page-165
-
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $22.01M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $11.58K | 987.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 2145720 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 240296 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 2145720 | 0.010 |
5 | 2335000 | 0.009 |
7 | 1209464 | 0.008 |
8 | 1774928 | 0.007 |
15 | 9394104 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 240296 | 1 |
0.012 | 2337063 | 4 |
0.013 | 1400000 | 3 |
0.014 | 566915 | 1 |
0.015 | 375000 | 1 |
Last trade - 13.55pm 15/07/2024 (20 minute delay) ? |
Featured News
SPQ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online